Publications and ressources

Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.

Michel Polak, Jacques Beltrand

Source :

Pmid / DOI:

Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.

Michel Polak, Athanasia Stoupa

Source :

Pmid / DOI:

TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology.

Aurore Carre

Source :

Pmid / DOI:

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.

Michel Polak, Jacques Beltrand

Source :

Pmid / DOI:

Thyroid Hypoplasia in Congenital Hypothyroidism Associated with Thyroid Peroxidase Mutations.

Aurore Carre, Athanasia Stoupa, Michel Polak

Source :

Pmid / DOI:

Update of Thyroid Developmental Genes.

Michel Polak, Athanasia Stoupa, Dulanjalee Kariyawasam, Aurore Carre

Source :

Pmid / DOI:

Mutations in BOREALIN cause thyroid dysgenesis.

Michel Polak, Aurore Carre, Athanasia Stoupa, Dulanjalee Kariyawasam

Source :

Pmid / DOI:

Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.

Michel Polak, Jacques Beltrand

Source :

Pmid / DOI:

RFX6 regulates insulin secretion by modulating Ca2+ homeostasis in human β cells.

Michel Polak

Source :

Pmid / DOI:

DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.

Michel Polak, Dulanjalee Kariyawasam, Aurore Carre

Source :

Pmid / DOI: